Drug name	Challenge drug name	Putative target	Function	Pathway	HBA	HBD	Molecular weight	cLogP	Lipinski	SMILES
MEDI3622	ADAM17	ADAM17	Differentiation	EMT/migration	-	-	-	-	-	Antibody (MEDI3622)
AZD5363	AKT	AKT1;AKT2;AKT3	Oncogenic signal	AKT/PI3K	8	5	428.9	1.18	0	c1cc(ccc1[C@H](CCO)NC(=O)C2(CCN(CC2)c3c4cc[nH]c4ncn3)N)Cl
MK2206	AKT_1	AKT*	Oncogenic signal	AKT/PI3K	6	3	407.5	3.24	0	c1ccc(cc1)c2cc3c(ccn4c3n[nH]c4=O)nc2c5ccc(cc5)C6(CCC6)N
Perifosine,KRX-0401	AKT_PIK3C	AKT*;PIK3C*	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
AZ13409007, AKTaz	AKT_SGK	AKT*;SGK*	Oncogenic signal	AKT/PI3K	8	3	459.3	2.25	0	COc1cc2c(cc1OC)C3(CCN(CC3)c4c5c([nH]nc5Br)ncn4)C[C@H]2N
AZ13361171	ALK	ALK	Oncogenic signal	AKT/PI3K	8	2	532.1	3.89	1	CN1CCN(CC1)C2CCN(CC2)c3ccc(c(c3)OC)Nc4ncc(c(n4)c5c[nH]c6c5cccc6)Cl
AZ13397262	ALK_2	ALK	Oncogenic signal	RTK	NA	NA	NA	NA	NA	NA
AZD3463	ALK_IGFR	ALK;IGF*R	Oncogenic signal	AKT/PI3K	7	4	449	4.08	0	COc1cc(ccc1Nc2ncc(c(n2)c3c[nH]c4c3cccc4)Cl)N5CCC(CC5)N
MDV3-100	AR	AR	Oncogenic signal	Hormonal	6	1	464.4	3.35	0	CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C2(C)C)c3ccc(C#N)c(c3)C(F)(F)F;CC1(C(=O)N(C(=S)N1c2ccc(c(c2)F)C(=O)NC)c3ccc(c(c3)C(F)(F)F)C#N)C
AZD3514	AR_1	AR	Oncogenic signal	Hormonal	9	0	519.6	2.38	1	CC(=O)N1CCN(CCOc2ccc(cc2)C3CCN(CC3)C4=Nn5c(CC4)nnc5C(F)(F)F)CC1;CC(=O)N1CCN(CC1)CCOc2ccc(cc2)C3CCN(CC3)C4=Nn5c(nnc5C(F)(F)F)CC4
AZ12618466,AZ13535704	ATM	ATM	DNA repair	DNA Damage Response	8	1	547.7	4.28	1	C[C@@H]1CN(C[C@@H](O1)C)CC(=O)Nc2ccc3c(c2)Cc4cccc(c4S3)c5cc(=O)cc(o5)N6CCOCC6
AZ13135223	ATR_1	ATR	DNA repair	DNA Damage Response	7	1	398.5	0.44	0	CS(=O)(=O)C1(CC1)c2cc(nc(n2)c3cccc4c3cc[nH]4)N5CCOCC5
AZ13242274	ATR_2	ATR	DNA repair	DNA Damage Response	7	1	412.5	0.96	0	C[C@@H]1COCCN1c2cc(nc(n2)c3cccc4c3cc[nH]4)C5(CC5)S(=O)(=O)C
	ATR_3	ATR	DNA repair	DNA Damage Response	NA	NA	NA	NA	NA	NA
AZD6738	ATR_4	ATR	DNA repair	DNA Damage Response	8	2	412.5	0.59	0	C[C@@H]1COCCN1c2cc(nc(n2)c3ccnc4c3cc[nH]4)C5(CC5)[S@](=N)(=O)C
Azacytidine,Vidaza	Azacytidine	Methylation	Differentiation	Epigenetic	NA	NA	NA	NA	NA	NA
AZ12849707	BCL2	BCL2	Cell death	Apoptosis	11	2	974.6	12.39	3	CC1(CCC(=C(C1)CN2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(c(c4)S(=O)(=O)C(F)(F)F)N[C@H](CCN5CCOCC5)CSc6ccccc6)c7ccc(cc7)Cl)C
AZ13453720	BCL2_2	BCL2	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
Obatoclax mesylate	BCL2_3	BCL2	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
AZD4320	BCL2_BCL2L1	BCL2;BCL2L1	Cell death	Apoptosis	11	4	945.5	9.62	3	CN(CC[C@H](CSc1ccccc1)Nc2ccc(cc2S(=O)(=O)C(F)(F)F)S(=O)(=O)NC(=O)c3ccc(cc3)N4CCC(CC4)[C@H](c5ccccc5c6ccc(cc6)Cl)O)CCO
Navitoclax	BCL2_BCL2L1_BCL2L2	BCL2;BCL2L1;BCL2L2	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
AZ13453202	BCL2L1	BCL2L1	Cell death	Apoptosis	9	2	651.8	3.05	1	CN(C)CC#Cc1ccc(OCCCc2sc(nc2C(=O)O)N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)cc1;CN(C)CC#Cc1ccc(cc1)OCCCc2c(nc(s2)N3CCc4cccc(c4C3)C(=O)Nc5nc6ccccc6s5)C(=O)O
YM-155,Sepantronium bromide	BIRC5	BIRC5	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
GDC-0879	BRAF_2	BRAF	Oncogenic signal	MAPK	NA	NA	NA	NA	NA	NA
AZ12799043	BRAF_M	BRAF_mut	Oncogenic signal	MAPK	8	4	498.5	2.08	0	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)c4cccc(c4)C(=O)N)c1F;CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)c4cccc(c4)C(=O)N)F
AZ12419304	BRAF_M2	BRAF_V600E	Oncogenic signal	MAPK	NA	NA	NA	NA	NA	NA
CHIR-265	BRAF_VEGFR2	BRAF;VEGFR2	Oncogenic signal	MAPK	NA	NA	NA	NA	NA	NA
Carboplatin	Carboplatin	DNA	DNA repair	Chemo	6	4	369.2	-	0	C1CC2(C1)C(=O)O[Pt](OC2=O)(N)N
Carboplatin,Paclitaxel	CarboTaxol	DNA	DNA repair	Chemo	NA	NA	NA	NA	NA	NA
MT-103,Blinatumomab	CD19	CD19 antibody	Differentiation	EMT/migration	NA	NA	NA	NA	NA	NA
AZD7762	CHEK1	CHEK1	DNA repair	DNA Damage Response	6	5	362.4	3.11	0	c1cc(cc(c1)F)c2cc(c(s2)C(=O)N[C@H]3CCCNC3)NC(=O)N
Chloroquine,Avloclor	Chloroquine	Thiamine	other	other	NA	NA	NA	NA	NA	NA
Cisplatin,Platinol	Cisplatin	DNA	DNA repair	Chemo	NA	NA	NA	NA	NA	NA
AZ13146895	CSNK2A1	CSNK2A1	Oncogenic signal	STK	10	3	447.5	3.02	0	CC(=O)Nc1cc(ccc1N(C)CCN(C)C)Nc2cc(n3c(n2)c(cn3)C#N)NC4CC4
AZ13250285	CSNK2A1_2	CSNK2A1	Oncogenic signal	STK	10	5	419.5	2.12	0	CC(=O)Nc1cc(ccc1N(C)CCN)Nc2cc(n3c(n2)c(cn3)C#N)NC4CC4
Docetaxel	Docetaxel	TUBB1;BCL2;MAP2;MAP4;MAPT;NR1I2	DNA repair	Chemo	15	5	807.9	4.08	2	CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(c5ccccc5)NC(=O)OC(C)(C)C)O)O)OC(=O)c6ccccc6)(CO4)OC(=O)C)O)C)O
AZ13047864, Doxorubicin	Doxorubicin	TOP*;DNMT1	DNA repair	Chemo	12	7	543.5	0.32	3	CC1C(C(CC(O1)OC2CC(Cc3c2c(c4c(c3O)C(=O)c5cccc(c5C4=O)OC)O)(C(=O)CO)O)N)O
AZD4877	EG5	KIF11	Differentiation	EMT/migration	NA	NA	NA	NA	NA	NA
Afatinib	EGFR	EGFR	Oncogenic signal	RTK	8	2	485.9	4.49	0	CN(C)C/C=C/C(=O)Nc1cc2c(cc1O[C@H]3CCOC3)ncnc2Nc4ccc(c(c4)Cl)F
Iressa,Gefitinib,AZD1839	EGFR_2	EGFR	Oncogenic signal	RTK	7	1	446.9	5.6	1	COc1cc2c(cc1OCCCN3CCOCC3)c(ncn2)Nc4ccc(c(c4)Cl)F
AZD8931	ERBB	EGFR;ERBB*	Oncogenic signal	RTK	8	2	473.9	4.51	0	CNC(=O)CN1CCC(CC1)Oc2cc3c(cc2OC)ncnc3Nc4cccc(c4F)Cl
AZ13620596	ESR1	ESR1	Oncogenic signal	Hormonal	NA	NA	NA	NA	NA	NA
Faslodex,,Fulvestrant	ESR1_1	ESR1	Oncogenic signal	Hormonal	NA	NA	NA	NA	NA	NA
Hydroxytamoxifen,Afimoxifene 	ESR1_2	ESR1	Oncogenic signal	Hormonal	NA	NA	NA	NA	NA	NA
Tamoxifen	ESR1_3	ESR1	Oncogenic signal	Hormonal	NA	NA	NA	NA	NA	NA
AZ13590091,AZ12756122	FASN	FASN	Metabolism	Metabolism	6	0	462.6	4.8	0	c1cc(ccc1c2ccc3c(c2)cco3)c4nc5cnccc5n4C[C@@H]6CCN(C6)C(=O)C7CC7
AZD4547	FGFR	FGFR1;FGFR2;FGFR3	Oncogenic signal	RTK	8	3	463.6	4.43	0	C[C@@H]1CN(C[C@@H](N1)C)c2ccc(cc2)C(=O)Nc3cc(n[nH]3)CCc4cc(cc(c4)OC)OC
AZ13479709	FGFR4	FGFR4	Oncogenic signal	RTK	NA	NA	NA	NA	NA	NA
Lonafarnib	FNTA_FNTB	FNTA;FNTB	Metabolism	Metabolism	NA	NA	NA	NA	NA	NA
Folinic acid (leucovorin),Fluorouracil,Irinotecan	FOLFIRI	DNA	DNA repair	Chemo	NA	NA	NA	NA	NA	NA
Folinic acid (leucovorin),Fluorouracil,Oxaliplatin	FOLFOX	DNA	DNA repair	Chemo	NA	NA	NA	NA	NA	NA
Gemcitibine,Gemzar	Gemcitabine	DNA;RRM1;TYMS;CMPK1	Cell death	Chemo	7	4	263.2	-0.71	0	c1cn(c(=O)nc1N)C2C(C(C(O2)CO)O)(F)F
RO4929097	gSEC	Gamma secretase	Differentiation	EMT/migration	NA	NA	NA	NA	NA	NA
Vorinostat,Zolinza	HDAC_4	HDAC*	Differentiation	Epigenetic	NA	NA	NA	NA	NA	NA
Entinostat	HDAC1_HDAC3	HDAC1;HDAC3	Differentiation	Epigenetic	NA	NA	NA	NA	NA	NA
AT13387,Onalespib	HSP90	HSP90AA1	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
AZD5582	IAP	NIAP;XIAP;BIRC2;BIRC3	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
AZ13245620	IAP_2	NIAP;XIAP;BIRC2;BIRC3	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
AZD7032	IGFR_2	IGF*R	Oncogenic signal	RTK	9	2	463.5	3.59	0	COc1cc(ccc1Nc2ncc(c(n2)c3cnc4n3cccc4)F)N5CCN(CC5)CCO
IGF-OSI	IGFR_3	IGF*R	Oncogenic signal	RTK	6	3	421.5	4	0	C[C@@]1(O)C[C@@H](C1)c2nc(c3ccc4ccc(nc4c3)c5ccccc5)c6c(N)nccn26;C[C@]1(C[C@@H](C1)c2n3c(c(ncc3)N)c(n2)c4cc5nc(ccc5cc4)c6ccccc6)O
AZ13088546	IGFR_4	IGF*R	Oncogenic signal	RTK	9	2	507	4.29	1	C[C@H](C(=O)N1CCC(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)c4cnc5n4cccc5)Cl)O
AZ12879988,AZ10234562	IKBK	CHUK;IKBK*	Cell death	Apoptosis	7	3	395.5	1.59	0	c1cc(c(c(c1)OCC2CC2)c3cc(c4c(n3)NC(=O)OC4)C5CCCNC5)O
AZD1480	JAK	JAK1;JAK2	Oncogenic signal	Cell Cycle	8	3	348.8	2.01	0	Cc1cc(n[nH]1)Nc2c(cnc(n2)N[C@@H](C)c3ncc(cn3)F)Cl
Mekinist,GSK1120212,Trametinib	MAP2K	MAP2K1;MAP2K2	Oncogenic signal	MAPK	6	2	615.4	4.84	1	CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5
AZD6244,Selumetinib	MAP2K_1	MAP2K1;MAP2K2	Oncogenic signal	MAPK	7	3	457.7	3.88	0	Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3Cl)Br)C(=O)NOCCO
GDC-0623	MAP2K_2	MAP2K*	Oncogenic signal	MAPK	7	3	456.2	3.22	0	OCCONC(=O)c1ccc2cncn2c1Nc3ccc(I)cc3F;c1cc(c(cc1I)F)Nc2c(ccc3n2cnc3)C(=O)NOCCO
MEK_GSK	MAP2K_3	MAP2K*	Oncogenic signal	MAPK	6	2	615.4	4.98	1	Cc1c2c(c(n(c1=O)C)Nc3ccc(cc3F)I)c(=O)n(c(=O)n2c4cccc(c4)NC(=O)C)C5CC5
Ro5126766	MAP2K_RAF	MAP2K1;MAP2K2;RAF1;BRAF	Oncogenic signal	MAPK	NA	NA	NA	NA	NA	NA
PF-04217903	MET	cMET	Oncogenic signal	RTK	9	1	372.4	0.52	0	c1cc2cc(ccc2nc1)Cn3c4c(ncc(n4)c5cnn(c5)CCO)nn3
ARQ197,Tivantinib 	MET_2	MET	Oncogenic signal	RTK	NA	NA	NA	NA	NA	NA
Crizotinib	MET_ALK	cMET;ALK	Oncogenic signal	RTK	6	3	450.3	4.29	0	C[C@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CCNCC4
AZD8055	MTOR	MTOR	Oncogenic signal	AKT/PI3K	9	1	465.6	2.59	0	C[C@H]1COCCN1c2c3ccc(nc3nc(n2)N4CCOC[C@@H]4C)c5ccc(c(c5)CO)OC
AZD2014	MTOR_1	MTOR	Oncogenic signal	AKT/PI3K	9	1	462.6	2.47	0	C[C@H]1COCCN1c2c3ccc(nc3nc(n2)N4CCOC[C@@H]4C)c5cccc(c5)C(=O)NC
Temsirolimus,Torisel	MTOR_2	MTOR	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
Everolimus,Zortress	MTOR_3	MTOR	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
INK128	MTOR_4	MTOR	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
Ridaforolimus,Deforolimus	MTOR_5	MTOR	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
MLN4924	NAE	NAE1;NAE2	Metabolism	Metabolism	NA	NA	NA	NA	NA	NA
Oxaliplatin	Oxaliplatin	DNA	DNA repair	Chemo	2	4	114.2	-0.62	0	C1CC[C@H]([C@@H](C1)N)N
AZD2281,Olaparib	PARP1	PARP1	DNA repair	DNA Damage Response	7	1	434.5	1.24	0	c1ccc2c(c1)c(n[nH]c2=O)Cc3ccc(c(c3)C(=O)N4CCN(CC4)C(=O)C5CC5)F
AZD2461	PARP1_2	PARP1	DNA repair	DNA Damage Response	6	1	395.4	0.73	0	COC1CCN(CC1)C(=O)c2cc(ccc2F)Cc3c4ccccc4c(=O)[nH]n3
MED-575	PDGFR_Ab	PDGFRA	Oncogenic signal	RTK	NA	NA	NA	NA	NA	NA
CAL-101,Idelalisib	PI3KCD	PIK3CD	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
GDC-0941, PI3K-abd	PIK3C	PIK3C*	Oncogenic signal	AKT/PI3K	10	1	513.6	2.63	1	CS(=O)(=O)N1CCN(CC1)Cc2cc3c(s2)c(nc(n3)c4cccc5c4cn[nH]5)N6CCOCC6
BKM120	PIK3C_2	PIK3C*	Oncogenic signal	AKT/PI3K	8	2	410.4	1.58	0	c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
PF-04691502	PIK3C_MTOR	PIK3C*;MTOR	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
XL765,SAR245409	PIK3C_MTOR_2	PIK3C*;MTOR	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
AZ13036220	PIK3CA_2	PIK3CA	Oncogenic signal	AKT/PI3K	7	1	365.4	2.56	0	CS(=O)(=O)c1ccc(Nc2cncc(n2)c3cnc4ccccn34)cc1;CS(=O)(=O)c1ccc(cc1)Nc2cncc(n2)c3cnc4n3cccc4
AZ13406193	PIK3CA_3	PIK3CA	Oncogenic signal	AKT/PI3K	7	1	318.3	3.12	0	COc1cc(cnc1)Nc2cncc(n2)c3cnc4n3cccc4
BYL-719	PIK3CA_4	PIK3CA	Oncogenic signal	AKT/PI3K	7	3	441.5	2.13	0	Cc1c(sc(n1)NC(=O)N2CCC[C@H]2C(=O)N)c3ccnc(c3)C(C)(C)C(F)(F)F
AZ12772848	PIK3CB	PIK3CB	Oncogenic signal	AKT/PI3K	NA	NA	NA	NA	NA	NA
AZD8186	PIK3CB_PIK3CD	PIK3CB;PIK3CD	Oncogenic signal	AKT/PI3K	7	1	457.5	1.67	0	CC(c1cc(cc2c1oc(cc2=O)N3CCOCC3)C(=O)N(C)C)Nc4cc(cc(c4)F)F
AZD1208	PIM1	PIM1	Oncogenic signal	STK	5	3	379.5	3.18	0	c1ccc(cc1)c2cccc(c2N3CCC[C@H](C3)N)/C=C\4/C(=O)NC(=O)S4
	PIP5K1	PIP5K1*	Metabolism	Metabolism	NA	NA	NA	NA	NA	NA
Enzastaurin,synthetic bisindolylmaleimide	PRKC	PRKC*	Differentiation	EMT/migration	NA	NA	NA	NA	NA	NA
AZ12594248,AZ13163036,AZ13150560	PRKDC_2	PRKDC	DNA repair	DNA Damage Response	8	1	582.7	4.39	1	CCN1CCN(CC1)CC(=O)Nc2ccc(c3c2c4ccccc4s3)c5cccc6c5oc(cc6=O)N7CCOCC7
Bortezomib,Cytomib	Proteasome	Proteasome	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
Carfilzomib,Kyprolis	Proteasome_2	Proteasome	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
AZ13041521	PTK2	PTK2*	Differentiation	EMT/migration	7	3	404.4	4.29	0	Cc1c(cn(n1)C)Nc2cc(c(cn2)C(F)(F)F)Nc3ccccc3C(=O)NC
AZ13257149	PTK2_2	PTK2*	Differentiation	EMT/migration	8	3	438.4	4.17	0	Cc1c(cn(n1)C)Nc2cc(c(cn2)C(F)(F)F)Nc3ccc(cc3C(=O)NOC)F
	SLC16A4	SLC16A3;SLC16A4	Metabolism	Metabolism	NA	NA	NA	NA	NA	NA
SN38	SN38	TOP1;TOP2*	DNA repair	Chemo	7	2	392.4	1.97	0	CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)O
AZD0530	SRC	SRC	Oncogenic signal	RTK	10	1	542	4.11	1	CN1CCN(CC1)CCOc2cc3c(c(c2)OC4CCOCC4)c(ncn3)Nc5c(ccc6c5OCO6)Cl
AZ13233395	SYK	SYK	Oncogenic signal	Cell Cycle	11	3	470.5	4.12	1	CC1(C(=O)Nc2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)C
AZD6474,Vandetinib,Zactima,Caprelsa	TKI	KDR;EGFR;RET	Oncogenic signal	RTK	6	1	475.4	5.84	1	CN1CCC(CC1)COc2cc3c(cc2OC)c(ncn3)Nc4ccc(cc4F)Br
Regorafenib,Stivarga	TKI_2	VEGFR2;TIE2	Differentiation	EMT/migration	NA	NA	NA	NA	NA	NA
TNF-Alpha	TNF	TNFA	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
TRAIL	TNFSF10	TNFSF10	Cell death	Apoptosis	NA	NA	NA	NA	NA	NA
AZ13590108	TNKS_PARP6	TNKS;PARP6	Oncogenic signal	Cell Cycle	NA	NA	NA	NA	NA	NA
AZ12623380	TOP2	TOP2*;PRKDC	DNA repair	DNA Damage Response	4	0	413.5	5.44	1	c1ccc2c(c1)c3cccc(c3s2)c4cccc5c4oc(cc5=O)N6CCOCC6
Etoposide	TOP2_2	TOP2*	DNA repair	Chemo	13	3	588.6	0.03	2	CC1OCC2C(O1)C(C(C(O2)OC3c4cc5c(cc4C(C6C3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O
Topotecan	Topotecan	TOP1;TOP1MT;DNA	DNA repair	Chemo	8	2	421.5	0.73	0	CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)CN(C)C)O)O
AZ12783146	TTK	TTK	Oncogenic signal	STK	9	1	452.6	3.62	0	Cn1c2cnc(nc2n(c1=O)C3CCCC3)Nc4ccc(cc4OC)OC5CCN(CC5)C
5FU,Fluorouracil	TYMS	TYMS	DNA repair	Cell Cycle	NA	NA	NA	NA	NA	NA
AZD2171,Recentin,Cediranib	VEGF	KDR;FLT1;FLT4	Differentiation	EMT/migration	NA	NA	NA	NA	NA	NA
Vinorelbine	Vinorelbine	microtubule;TUBB	DNA repair	Chemo	12	2	778.9	5.94	3	CCC1=C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CN(C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CCN9[C@H]8[C@@](C=CC9)([C@H]([C@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC
AZD1775	WEE1	WEE1	DNA repair	DNA Damage Response	NA	NA	NA	NA	NA	NA
AZ13401366	WNT	WNT*;TNKS	Differentiation	EMT/migration	NA	NA	NA	NA	NA	NA
